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Abstract
International public health workers are challenged by a burden of arthropod-borne disease that remains elevated
despite best efforts in control programmes. With this challenge comes the opportunity to develop novel vector
control paradigms to guide product development and programme implementation. The role of vector behaviour
modification in disease control was first highlighted several decades ago but has received limited attention within
the public health community. This paper presents current evidence highlighting the value of sub-lethal agents,
specifically spatial repellents, and their use in global health, and identifies the primary challenges towards
establishing a clearly defined and recommended role for spatial repellent products in disease control.
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Background
Arthropod-borne diseases, such as malaria and dengue,
remain significant health problems worldwide despite dec-
ades of organized vector control [1,2]. The reasons for this
are complex and include both limited option and availabil-
ity of active ingredients (AIs), and a lack of understanding
of all actions and mechanisms that such AIs exert against
the target insects (Figure 1). A better understanding of such
actions would help in the design of alternative application
formats for global vector control strategies beyond the
current choices of insecticide-treated bed nets (ITNs) and
indoor residual spraying (IRS). For decades, research and
development in vector control have taken a secondary pos-
ition to development of other methods of disease control –
namely chemotherapy and vaccines. Simultaneously, the
focus of efforts in vector control was on ITNs with minimal
emphasis on other vector control strategies. As a conse-
quence, there is now an urgent need to improve current
tools and advance the development of novel products based
on new paradigms that function through alternative
mechanisms of action – i.e., vector behaviour modification
that specifically includes spatial repellency (SR).
Currently, there are 15 AI compounds recommended by
WHO for adult insect vector control restricted to only four
chemical classes, with the most recent addition - etofen-
prox (pyrethroid) - occurring in 1999 [3,4]. Twenty years
on, the global community continues to place expectations
of population-level protection using these very same, lim-
ited groups of actives in the same way on walls of houses
and bed nets. Although this limited arsenal of AIs and
application modalities has contributed to decreasing the
malaria burden, it is becoming grossly inadequate to sus-
tain reductions in disease burden in many endemic coun-
tries. This is due, in part, to an overreliance on pyrethroids
(which dominate the WHO shortlist of approved AIs) in
both public health and agriculture and a resultant increas-
ing occurrence of insecticide resistance, coupled with vari-
able and poorly understood ecologies of different vector
species [5].
No new classes of traditional vector control insecticides
have been developed in recent decades (excluding refor-
mulated active ingredients), therefore there is reason to
assume that very few such compounds, if any, are currently
in the development pipeline and expected for use in the
near future. New AIs that have been explored and are ripe
for development lack the important characteristic of repel-
lency [6,7]. It is these significant behavioural effects, and
alternative mechanisms of action that should be exploited
for the development of innovative vector control products
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to better manage current and mitigate future insecticide
resistance problems. The wider effort could be enhanced
by broadening the scope of AI discovery to include screen-
ing criteria that identify compounds and/or chemical
classes that exploit behavioural modification as a means to
disease reduction [8].
The use of spatial repellents to create a vector-free
space, thereby preventing contact between human and
vector, thus preventing disease transmission, is demon-
strably effective [9-22]. Yet, use of spatial repellency is
neither endorsed nor recognized as a component of a
multilateral disease control strategy. There are multiple
rationales that argue in favour of a change in this policy.
Benefits of sub-lethal over more conventional lethality-
directed chemical approaches include: 1) marketable for
insecticide-management purposes because its useful for
delaying the onset of resistance to active ingredients used
for ITNs or IRS; 2) effective for outdoor protection,
something that IRS and ITNs have little impact on; 3)
useful in attacking other components of vector behav-
iour such as pre, during and post-host-seeking, i.e. to
disrupt critical behavioural sequences that can prevent
blood-feeding (and disease transmission) and strengthen
the effectiveness of integrated vector control strategies;
4) employable against multiple vectors, behaviours and
species – not just those that feed and rest inside houses -
and subsequently against other arthropod-borne diseases,
and 5) useful against economically important insects, espe-
cially agricultural pests, where market forces will fuel the
cost of AI discovery and development. Indeed, strategies
such as a push-pull system that integrates repellents or mat-
ing disruptors with attractants and trapping methods, have
successfully been implemented for agricultural pest control
and are currently under investigation for vector control [23].
Incentives for changing the prevailing screening and evalu-
ation paradigms for chemical control products should be
driven through an evidence-based approach. Over the past
several years, four formal national and international meet-
ings [24] were convened to bring together academics, indus-
try and global public health experts, including
representatives from the WHO and the WHO Pesticide
Evaluation Scheme (WHOPES) [25], to discuss the role of
spatial repellent chemicals, whose effects are not reliant on
acute toxicity or lethality, in the reduction of arthropod-
borne diseases. A critical aspect of these meetings and subse-
quent efforts has been to establish a critical path of develop-
ment for these products (SRCPD). The principal goal of the
SRCPD is to gain formal acceptance of the requirement for
the development and incorporation of spatial repellent-
based strategies as integral components for disease vector
control from global health authorities such as WHOPES. As
such, the adoption of a widely accepted SRCPD is expected
to create opportunities and impetus for industry, academia
and other private/public sector entities to increase ongoing
efforts to discover, validate and develop novel repellent AIs
that represent classes of chemicals that focus on vector be-
havioural modification rather than toxicity/lethality as well
as find new means of utilizing existing compounds in
Figure 1 The general concept of spatial repellency is clear: to prevent an arthropod from entering a space occupied by a potential human
host to reduce encounters between humans and vectors thereby eliminating or reducing the probability (risk) of pathogen transmission to either
insect or human.
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behavioural disruption. This strategic document is expected
to aid in a comprehensive effort to develop and eventually
deploy innovative control methods for either stand-alone
products and/or integrated interventions for combating
vector-borne diseases.
The intention of this paper is to disseminate key out-
comes of the core working group, to highlight known
and potential benefits of spatial repellency, identify spe-
cific obstacles and challenges to the successful develop-
ment of spatial repellent tools, and to highlight key
components of the SRCPD needed to achieve the goal of
recommending spatial repellents as a viable means for
disease prevention (Table 1).
Making choices: repel or kill? Evidence of value
Spatial, or area repellents (also known as deterrents [26])
are defined here as chemicals that work in the vapor
phase to prevent human-vector contact by disrupting
normal behavioural patterns within a designated area or
“safe zone” (e.g. a space occupied by potential human
hosts) thus making the space unsuitable for the insect
(Figure 2). Depending on efficacy of the AI and applica-
tion modality, this would result in a vector-free (or
greatly reduced / suppressed) area. The unique benefit of
SR is that the safe-zone can include specific areas both
indoors and outside. The volume of space that is ‘pro-
tected’, or minimum protection range, will be dependent
on the properties of the AI, application platform and/or
environmental conditions (e.g. air flow, temperature and
humidity). Regardless of the particulars, the general con-
cept of spatial repellency is clear: to discourage an
arthropod from entering a space occupied by a potential
human host thus reducing encounters between humans
and vectors thereby eliminating or reducing the prob-
ability (risk) of pathogen transmission to either insect or
human.
The current prevailing strategic paradigm in vector control
is that effective delivery of an acutely toxic compound will
have the greatest impact for disease suppression by
reducing the survival of the overall vector population, a con-
cept based on the classic Ross-Macdonald model used for
advocating DDT IRS during the Global Malaria Elimination
Programme in the 1950s-1960s. If correct, what is the
rationale for removing or otherwise deterring a vector from
a specified space without directly killing it? If spatial repel-
lency to prevent bites were to be the primary control mech-
anism, malaria transmission will be reduced if mosquitoes
1) are diverted to alternative non-human hosts which can-
not carry malaria, and/or 2) feed, reproduce and survive less
because humans are difficult to access and no alternative
source of blood is available [19]. The result will be reduc-
tions in numbers of both humans and vectors being
infected and this result has a dramatic effect on mathemat-
ical models of malaria transmission [27].
The immediate advantages of modifying vector behaviour
that results in movement away from a human host, is a
delayed or diminished development in the emergence of in-
secticide resistance by minimizing the intensity of selection
pressure from contact-mediated toxicity mechanisms as
well as the potential reduction of toxic effects of a chemical
to human and non-target organisms. The added long-term
benefits of demonstrating disease impact of spatial repel-
lents include the discovery and development of new chem-
ical active ingredients and/or new modes of action that
target and exploit the normal vector behavioural patterns
outside and surrounding the home while in search of a
host. A better understanding of vector behaviour in this
context can stimulate innovative product development and
enhance vector control. The accumulated long-term effects
of such deterrent events upon mosquito life histories can
reduce malaria transmission by forcing mosquitoes to
either feed upon non-human hosts or to search more
broadly for alternative blood (and subsequently oviposition
sites), thereby reducing human blood indices, vector sur-
vival, feeding frequency and reproduction rates. It is likely
that, the longer a vector remains exposed to harsher and
more demanding outdoor conditions the more likely it is
that the vector will die. Outdoors, vectors risk greater pre-
dation, physiological stressful environments, and excessive
energy expenditure during host-seeking, or identifying a
resting or oviposition site [19]. In essence, the vector popu-
lation will potentially experience greater adverse environ-
mental exposure and therefore mortality without chemically
induced selection pressure thereby potentially increasing the
sustainability of existing and novel chemical interventions.
Furthermore, vector populations that survive exposure to
sub-lethal, spatial repellents may subsequently show per-
manent or semi-permanent disruption of host-seeking and
blood-feeding behaviours [28]. The reduction in host-
contact/feeding success could ultimately lead to reduced
overall numbers and survival of older mosquitoes that trans-
mit mature infectious stage parasites, thereby suppressing
transmission at the community level –a more subtle means
to achieve the desired outcome of traditional adulticidal
strategies [19].
Table 1 Summary points outlining role of spatial repellents
and requirements for adoption in vector control
Summary points
•The discovery, development and use of novel vector control tools will
be required to achieve the goal of malaria elimination and eradication
•Evidence exists of the benefits of sub-lethal approaches for interrupting
human-vector contact but epidemiological data is insufficient to
influence policy-makers to recommend spatial repellent tools for
disease control confidently
•The adoption of a new paradigm shift in vector control to include
behavior modification will require a new set of laboratory and field
assay tools, standardized endpoints and analyses which must also be
endorsed and adopted by leading global public health authorities
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The case for developing a SRCPD is strengthened by sev-
eral research programmes that have, and continue, to gen-
erate evidence of the benefits of sub-lethal approaches for
disease control. Studies evaluating physical barriers (e.g.
house screening and untreated bed nets) have shown re-
duction on disease burden in the absence of vector lethality
[20,21]. Specifically, a randomized controlled trial where
screening houses resulted in a 50% reduction in malaria
vectors entering the house, produced a 50% reduction in
anaemia in young children. In this study, houses were
screened with untreated netting and, since they ‘repelled’
mosquitoes and did not kill them, they were protected in a
similar manner to that expected for spatial repellents. Fur-
ther evidence exists describing the potential effects of sub-
lethal toxic chemicals and disease reduction [9-22]. Indeed,
beginning in the 1940s, numerous observations were made
on the ability of DDT (arguably the most effective chemical
tool so far developed to reduce arthropod-borne disease
burden in history) to create a vector-free space [29]. When
DDT was sprayed on the interior wall surfaces of houses,
there were essentially no mosquitoes to be found indoors,
with malaria rates subsequently declining dramatically and
vector populations were reduced overall [10,11,17]. Those
results are attributed primarily to the spatial repellent ac-
tion of DDT (a significant and generally underrated prop-
erty) and not the toxic action alone [30]. This conclusion is
based on numerous observational and quantitative studies
that clearly indicate the primary action of DDT is spatial
repellency with ‘irritancy’ (contact excitation) and toxicity
as secondary and tertiary effects of lower order [12-19].
Furthermore, a dramatic and unmistakable reduction in
disease incidence has been documented following IRS with
DDT even in areas with significant DDT-resistant vector
populations [31]. This paper is not designed to argue the
use of DDT in vector control programs. Instead, it aims to
highlight the spatial repellent characteristics of the AI to
provide a significant example of the role and value of
behavior modification in disease control.
A paradigm shift from contact toxicity-based strategies
to a broader approach using behaviour-modifying AIs
and modalities that can operate safely at a distance, will
require clear evidence that demonstrate: 1) chemicals
can exert behaviour-modifying characteristics relating to
vector/host interactions (via entomological validation); 2)
that peripheral exposure to such chemicals is not harm-
ful or otherwise unfavourable to humans, and 3) sub-
lethal approaches to vector control can significantly im-
pact disease transmission (via epidemiological valid-
ation). Of these, chemical-based behaviour modification
has been comprehensively demonstrated under both
laboratory and field conditions [12-16]. Although histor-
ical data exists supporting the associated sub-lethal
effects on disease risk reduction [10,17], no controlled
study design has been implemented to specifically correlate
spatial repellency actions with direct, real-time impact on
disease incidence.
Figure 2 The fundamental choice between killing mosquitoes and deterring them: mosquitoes that abort attacks on humans because of
sub-toxic exposure are, by definition, not exposed to toxic levels that kill them (Killeen GF and Moore SJ with permission).
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Expectations
Human populations have long been aware that using per-
sonal repellents and deterrents can reduce biting from
blood-sucking insects and utilize these materials widely, even
when associated with marked financial costs [32]. In econ-
omies that can support even minimal discretionary spending,
it is not uncommon to observe use of electric fans or topical
repellents to reduce biting burden and/or the purchase of
various commercial products, including insecticidal powders,
aerosols, nets, and coils that function by toxic (acute-kill)
chemical actions. Spatial repellent actives could be integrated
into such consumer products or used to enhance IRS and
ITN programmes, where appropriate, to provide added pro-
tection to individuals, households and communities using
AIs with minimal mammalian toxicity. However, the public
health community must think beyond current formats and
consider novel consumer-based products that increase mar-
ket value and thereby compliance and sustainability by com-
bining end-user “wants” (i.e. products that provide utility or
beautification, such as decorative mats, clothing, etc.) with
vector control thereby creating opportunities for innovative,
cost-effective and affordable vector control delivery plat-
forms. Marketing these tools through a consumer product
channel poses a viable solution to managing burden of prod-
uct delivery to target populations [32].
It is realistic to conceptualize a spatial repellent product
that can be adapted to exterior areas of homes or within
the immediate peri-domestic environment to effectively
protect a wider spatial area from pathogen transmission
throughout both evening and daytime hours. In fact, in the
face of elimination/eradication of malaria, it is becoming
more evident that those vectors with behaviours which are
not controlled by conventional IRS and ITNs or spaces
where physical structures are absent, will become the focus
of residual transmission and will be the barrier to success
or failure [26,33]. When one considers the human popula-
tion at risk of transmission outdoors, the niche for spatial
repellents becomes increasingly evident due to the lack of
current control products for those humans becoming
infected in these areas [34,35] (Figure 3). What tools we cur-
rently have are not enough. The role of combined organized
vector control (IRS and ITNs) with personal protection
(consumer products) to enhance human protection from
infection is upon us and where SR could equally be useful.
Such products could be disseminated in a variety of
delivery platforms: as stand-alone consumer products or
designed to be integrated into community-based or
vertically organized vector control programmes. By
applying separate products with very different, comple-
mentary modes of action to distinct fractions of trans-
mission sites, it may be possible to both extend rather
than duplicate coverage of transmission per se and ex-
ploit the benefits of SR against direct-toxicity. Given
that repellent actions and mechanisms are independent
of toxicity and the necessity for direct contact with a
treated surface is averted, the authors envision a spatial
repellent active ingredient that is effective against vari-
ous genera and species of disease vectors, either insecti-
cide resistant or susceptible, that can be adapted to a
plethora of conditions.
Hurdles to overcome
In order for a spatial repellent product to enter into the
market, a set of development criteria must be met. These
include measures related to scientific, regulatory and social
parameters. In part, these criteria will comprise the SRCPD
and outline the endpoints of a target product profile for a
spatial repellent product. The authors have chosen to de-
scribe three major hurdles identified in the SRCPD
(Table 2).
1. Generation of sufficient epidemiological data to
influence policy-makers to recommend the incorpor-
ation of spatial repellents into current multi-lateral
disease control programmes confidently. The concept
of spatial repellency will be accepted once indisputable
proof-of-principle that a spatial repellent can reduce
human disease through sub-lethal chemical actions is pro-
vided. While associations between SR and reduced disease
transmission have been made, they generally exist in two
incomplete formats: epidemiological data post-chemical
treatment that lacks a sufficient entomological component
or evaluation of changes in entomological endpoints due to
repellency without supporting case data that measures dis-
ease impact [9-22]. To date, no published accounts linking
epidemiological and entomological components exist for
spatial repellents, thus there is a critical need for Phase III
community trials integrating simultaneous monitoring of
infection incidence with vector population metrics (i.e. par-
ity, sporozoite rates, blood meal indices, abundance etc.),
one of which is currently underway. Such confirmatory
studies will require unambiguous entomological measures
of repellency versus irritancy and/or knock down effects in
reducing vector entry into a given interior space or outside
area, as well as reductions in vector biting densities (to in-
clude potential redirection to untreated spaces with human
hosts) concurrent with reduced pathogen transmission.
The challenge arises when designing an impact study to en-
sure both entomological and parasitological endpoints cor-
relate with true repellency effects.
2. Identification and validation of the entomological
end points that predict a public health impact using
spatial repellency. There are three AIs currently regis-
tered by the USEPA for outdoor use as vaporizing spatial
repellents (allethrin, pyrethrin and metofluthrin). Pralle-
thrin, permethrin and cyflutrhin when used as aerosols
and/or surface sprays also have SR claims. However, the
endpoint used to label them as spatial repellents is anti-
biting. These pyrethrum and pyrethroid-based products
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are all known to have knock down and toxicity at defined
concentrations. These products may be sufficient to
achieve our public health goals. If they are not, then effect-
ive screening systems will have to be established. A critical
element of that process will be establishing end points.
Currently, there is no consensus about what those end
points may be and the best means to quantify them. Crit-
ical endpoints may include reduced entry into a treated
space, reduced abundance within a space, and enhanced
exit from a space. Furthermore, the end points will have to
be accurately quantified. How far must any of those mea-
sures have to shift in order to create a reduction in patho-
gen transmission? How do shorter 24-hour measures of
those parameters, currently used in routine testing, relate
to the cumulative impact over the days or weeks of a
transmission season? Once the end points for evaluating
SR have been established (identified and validated) effect-
ive screening can begin. We will need to lobby our indus-
try partners to engage in the systematic screening of
spatial repellency in either existing chemical libraries and/
or discovery of novel chemical classes for vector control.
3. Motivating an objective, universally acceptable
paradigmatic shift in the current screening protocols
for the assessment and discovery of chemical vector
control products. In order to generate spatial repellent
products, the scientific community must have well defined,
effective active ingredients. Current laboratory screening
protocols utilize knock down and mortality as sole criteria
for advancing compounds to the next level in the screen-
ing process [8]. Even with disease impact studies and a vast
market potential for repellent products there will be a
Table 2 Key components of a spatial repellent critical
path of development (SRCPD)
Key components of a SRCPD
1 Proof-of-Principle: demonstrating a spatial repellent will impact
disease at the community level
2 Correlating entomological endpoints with reduction in infection
incidence rates using repellent tools
3 Measuring the impact of diversion of repelled vectors to untreated
sources under varying transmission dynamics
4 Defining the limitations of spatial repellency in both susceptible and
insecticide resistant vector populations
5 Developing standardized protocols and measures for the evaluation of
vector behavior modification as it relates to host-feeding following
exposure to spatial repellents (i.e., host-seeking, feeding, resting, and
oviposition) to identify long-term effects of spatial repellents
6 Engagement and recruitment of industry and academic partners to
adopt standardized protocols and measures for the screening of
chemical AIs to include spatial repellency
7 Identifying the underlying genetic/neurobiological basis of vector
behaviors to provide insight into the rationale design of new
repellents
Figure 3 An outdoor role for spatial repellents? Mathematical models show that the best strategy for application of spatial repellents depends
on the vector. Indoors and outdoors use is best for those vectors least susceptible to LLINs/IRS, while use of spatial repellents outdoors is best to
complement LLINs/IRS in areas where vectors feed indoors on humans (Killeen, GF and Moore, SJ with permission).
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requirement to adopt, via scientific community consensus,
a new set of laboratory and field assay tools, standardized
endpoints and analyses. These must come from a consen-
sus within the scientific and development communities
and must be sufficiently clear and uniform to provide reli-
able and reproducible results to evaluate behavioural
responses of a candidate spatial repellent. In order to pro-
mote worldwide recognition of spatial repellents for use in
vector control, these new testing protocols and overall
evaluation schemes must also be endorsed and adopted by
leading public health authorities such as WHOPES. Cur-
rently, WHOPES has standard evaluation protocols for
insecticides as contact irritants and toxicants; however,
there is an absence of standard protocols for evaluating
the behavioural effects of spatial repellent AIs with corre-
sponding endpoints. It is expected that a screening cascade
will need to be developed to allow the step-wise identifica-
tion of candidate compounds. This cascade should exploit
each assay’s sensitivity in an ordered, procedural manner.
For example, the process could begin with high-throughput
to include an intracellular evaluation (i.e., gene expression
and/or electrophysiological responses) or novel molecular
target that can be screened via heterologous expression
platforms. Discovery-based efforts would then advance to a
laboratory and then semi-field behavioural systems,
through to controlled experimental hut studies under field
conditions. One essential part of this process will be to de-
fine the mode(s) of action of active ingredients that elicit
the desired behavioural effect. This fundamental informa-
tion will aid the development of effective and efficient
screening tools and means of exploiting new AIs. The
promising news is that there are several electrophysiological
and behavioural assays with correspondingly robust analyses
currently being used in vector biology research that could
be incorporated into such schemes once adopted by
WHOPES and the wider scientific community [16,36-42].
Future directions
The ultimate goal of this working group is to provide a
basis for the recommendation by public health authorities
for the incorporation of spatial repellent products in multi-
lateral efforts focused on disease vector control. The success
of this effort will depend on a concerted effort between pub-
lic health entities, regulators, industries, non-governmental
agencies and sponsors, and academic partnerships coordi-
nated through a formal consortium which the authors
now propose: Advancing Repellency to Recommendation
Consortium (ARRC) to facilitate the planning, implementa-
tion and data dissemination for priority research studies as
outlined in the SRCPD. The focus of ARRC will be to con-
tinue developing a structured effort to increase the number
of potential and efficacious spatial repellent tools following a
precise SRCPD format beginning with the identification of
priority research areas. Combined, datasets from these
studies will provide insight into the rational design of new
repellent active ingredients, establish critical baseline data
and generate consensus on essential outcome measures and
data interpretation required for evaluation of the efficacy of
repellent products and control strategies.
Summary
Despite many decades of concerted effort along a number of
fronts, the long and difficult battle to control vector-borne
diseases continues. It is incumbent on the international dis-
ease control community to step up to this challenge and em-
brace both the need and opportunity for innovation. It is
accepted this includes not only the attempt to use available
tools optimally but also develop new ones to improve vector
control. The authors take the view that control of pathogen
transmission by preventing vectors from entering human-
occupied spaces is both beneficial and cost-effective and that
efforts to dramatically increase investments and efforts to
develop novel spatial repellent tools and strategies are
urgently needed.
Paradoxically, the value of vector behaviour modification
in disease control has been recognized for many decades
but largely under-appreciated. As a consequence, it is likely
that potentially effective chemicals and novel products have
been missed or overlooked. With current efforts focused on
the elimination and eventual eradication of vector-borne
diseases such as malaria, this must change [43]. It is the
authors’ goal that this article will bring renewed awareness,
stimulation and focus to the importance of spatial repel-
lency as an effective tool in the fight against vector-borne
disease transmission. By doing so it is hoped that further
discussion and a sustained investment in R&D will be
quickly forthcoming in order to bring a new generation of
effective chemicals and novel products into the disease con-
trol/eradication armamentarium.
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